Hong Kong Med J 2024;30(Suppl 1):S27-8
Radiosensitivity index as a predictive biomarker for radiotherapy de-intensification in nasopharyngeal carcinoma: abridged secondary publication
CL Chiang1, WMA Lee1, CWH Choi2, KCR Ngan2, WT Ng1, HFV Lee1, TC Lam1, KO Lam1, KC Tsang1, WHJ Wong3
1 Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
2 Division of Epidemiology and Biostatistics, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
3 School of Biomedical Science, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
 
 
  1. The radiosensitivity index is a potential predictor for locoregional control in radiotherapy-treated patients with locally advanced nasopharyngeal cancer.
  2. Owing to the small sample size, the association between radiosensitivity index and late toxicity is inconclusive.